New ‘Cluster Bomb-Like’ Drug Could Become Cure For Acute Leukemia, Israeli Scientists Say
August 26, 2018
“This article was re-published with permission from NoCamels.com – Israeli Innovation News.”
Israeli scientists from the Hebrew University of Jerusalem say they have developed a new drug that could become part of a future cure for acute leukemia, more specifically Acute myeloid leukemia (AML), after initial lab tests on mice showed a 50 percent success rate.
AML, an aggressive cancer of the blood and bone marrow, is the second most common type of cancer diagnosed in adults and children, but is found more frequently in adults. The known treatments are several decades old and the survival rates depends on a number of biological factors, including features of the disease and the age of the patient, but generally, approximately 25 percent make it past five years.
These blasts can stop the body from making healthy, normal cells which will lead to a “lack red blood cells that carry oxygen, platelets that prevent easy bleeding, and white blood cells that protect the body from diseases… because their body is too busy making the leukemic blast cells.
”To continue reading this article on NoCamels.com, click here.”
